Anders D Hove

Anders D Hove has an estimated net worth of $227 Million. This is based on reported shares across multiple companies, which include ARCA biopharma, Inc., Anacor Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc, Inspire Medical Systems, Inc., NEUROCRINE BIOSCIENCES INC, IRONWOOD PHARMACEUTICALS INC, Avalanche Biotechnologies, Inc., Edge Therapeutics, Inc., ALIMERA SCIENCES INC, Chelsea Therapeutics International, Ltd., WORLD HEART CORP, and OnKure Therapeutics, Inc..

2010 was Anders D Hove's most active year for acquiring shares with 14 total transactions. Anders D Hove's most active month to acquire stocks was the month of September. 2016 was Anders D Hove's most active year for disposing of shares, totalling 19 transactions. Anders D Hove's most active month to dispose stocks was the month of March. 2010 saw Anders D Hove paying a total of $22,366,788.50 for 9,755,155 shares, this is the most they've acquired in one year. In 2015 Anders D Hove cashed out on 6,463,520 shares for a total of $115,209,962.00, their largest year based on trade value.